
How AI is transforming corporate finance
According to Pigment's latest CFO survey, most companies missed their financial targets last year. This isn't just a sobering statistic—it's a clear wake-up call. In today's volatile environment, businesses can no longer afford to wait and react; they must anticipate and move faster than the market to stay ahead. Finance leaders need tools that not only keep pace with a rapidly shifting global economy but also enable proactive scenario planning. Artificial Intelligence has emerged as the most powerful tool to meet this challenge—helping businesses pivot with the same speed and agility that today's business landscape demands.
AI is ushering in a new era of smarter, faster, and more strategic decision-making in the office of the CFO. Finance leaders must now embrace AI not just to boost insights and productivity, but to drive more transformative, strategic outcomes. Teams are leveraging AI to access data faster, forecast more accurately, and collaborate seamlessly across the organization—often through simple natural language prompts. But the next evolution is underway: autonomous AI agents.
These systems don't wait for prompts; they operate continuously in the background, proactively handling complex tasks with minimal human intervention. From real-time forecasting and dynamic scenario planning to risk management and anomaly detection, AI agents will become essential tools in the finance function. The right investments today won't just streamline operations—they will fundamentally redefine how finance teams drive value, resilience, and competitive advantage for the business.
The Rise of Finance AI Agents
The latest tariff developments and world trade saga are causing financial leaders and their institutions a lot of headaches. Trade policy is notoriously complex for businesses to navigate. CFOs must assess not only the downstream impact of specific regulations on functions like their supply chain but also how their business may be affected by the wider impact on regional and global economies. But fortunately for CFOs, there is a silver lining.
The introduction of AI agents for finance teams has opened new doors to autonomous planning, real-time insights, and more proactive risk mitigation. AI agents can do more than just streamline processes like reconciliation and financial reporting—they can work independently and proactively as an extension of the team to help CFOs stay one step ahead of today's fast-moving business environment.
Imagine a world where a forecasting model not only reacts to past trends but also continuously learns from new data, anticipates market shifts, and updates projections in real time. AI agents can simulate the financial impact of global events—from supply chain disruptions to new regulatory policies—and run thousands of scenarios to understand how these could impact the business well before the numbers show up on the balance sheet. This enables CFOs to help their businesses better decide the best course of action to take. AI agents are poised to be a game-changing technology for CFOs and finance teams—but only if they are ready to embrace the change.
Making Smart Bets
When new technology emerges, there is huge upside but also equal risk for first movers and early adopters. For CFOs, the key to navigating through the AI hype cycle to make smart and grounded investments lies less in being an expert in emerging technologies and more in understanding your business and what you aim to achieve.
First, it's critical to understand the problem you're trying to solve with AI and the end goal: Are you trying to cut costs? Improve productivity? Looking for internal or external use cases? Most CFOs today are looking for ways that AI can help reduce spending and time spent on repetitive tasks, so their team can focus time elsewhere. But productivity is just one area that AI can drive value for businesses. CFOs should also think about how AI can democratize data for teams to be more strategic and even help make better business decisions and manage risk.
No matter the primary goal for AI adoption—in order to maximize the ROI on AI investments—it's essential to have the right foundations in place. AI can only be as good as the data you feed it. If data sources are poor quality, disparate, or inaccurate then you will get lackluster results no matter how powerful the AI capabilities might be. Related, adding AI to an already complex platform can frustrate teams rather than help them. Platforms that integrate easily with data sources—and clean up data during implementation—make AI reliable and accessible for nontechnical users to maximize its value. AI agents operate best when supported by the right architecture. It is critical that they are embedded in a platform that is AI-first, flexible, and intuitive, while also having access to accurate, real-time data in order to deliver transformational value, fast.
Finally, for AI to be truly effective and seamless, it requires an organization-wide strategy. CFOs should work alongside their CTOs and CIOs to ensure their data foundations are sound so that when new tools or platforms are added, teams can trust the data and outputs from AI are accurate. It also helps to start small. Get clear on exactly the use case for AI and test this out before building it out further.
The Next Move is Yours
The opportunity to become an AI-empowered finance organization is there for the taking. CFOs who want to give their teams the best chance to succeed and exceed expectations should not wait to make their move. According to McKinsey, 78% of business leaders say AI has already improved operational efficiency and decision-making in their organizations. And forward-thinking CFOs are already piloting AI in planning and analysis workflows, fraud detection, and even ESG reporting. The results? Greater accuracy, faster turnaround, and a better handle on risk. Those who delay risk being outpaced by competitors who are already harnessing AI to steer their companies with precision through these uncertain times.
AI isn't just about unlocking new levels of efficiency—it's about giving finance teams better access to the insights they need to make faster and more informed decisions in a more challenging and unpredictable world. Agents in particular have the power to change a business's trajectory and results—finding new pathways to accelerate growth, drive higher margins, and identify the right opportunities to make trade-offs. CFOs who embrace this shift and harness the power of AI won't just have a significant edge over their competition—they'll lead and redefine their industries.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
33 minutes ago
- Yahoo
Do AlzChem Group's (ETR:ACT) Earnings Warrant Your Attention?
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story even if these companies are loss-making. Sometimes these stories can cloud the minds of investors, leading them to invest with their emotions rather than on the merit of good company fundamentals. While a well funded company may sustain losses for years, it will need to generate a profit eventually, or else investors will move on and the company will wither away. In contrast to all that, many investors prefer to focus on companies like AlzChem Group (ETR:ACT), which has not only revenues, but also profits. Now this is not to say that the company presents the best investment opportunity around, but profitability is a key component to success in business. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. If a company can keep growing earnings per share (EPS) long enough, its share price should eventually follow. Therefore, there are plenty of investors who like to buy shares in companies that are growing EPS. Shareholders will be happy to know that AlzChem Group's EPS has grown 27% each year, compound, over three years. If the company can sustain that sort of growth, we'd expect shareholders to come away satisfied. Careful consideration of revenue growth and earnings before interest and taxation (EBIT) margins can help inform a view on the sustainability of the recent profit growth. The music to the ears of AlzChem Group shareholders is that EBIT margins have grown from 11% to 14% in the last 12 months and revenues are on an upwards trend as well. Ticking those two boxes is a good sign of growth, in our book. The chart below shows how the company's bottom and top lines have progressed over time. For finer detail, click on the image. View our latest analysis for AlzChem Group Of course the knack is to find stocks that have their best days in the future, not in the past. You could base your opinion on past performance, of course, but you may also want to check this interactive graph of professional analyst EPS forecasts for AlzChem Group. It's pleasing to see company leaders with putting their money on the line, so to speak, because it increases alignment of incentives between the people running the business, and its true owners. AlzChem Group followers will find comfort in knowing that insiders have a significant amount of capital that aligns their best interests with the wider shareholder group. To be specific, they have €42m worth of shares. This considerable investment should help drive long-term value in the business. Even though that's only about 3.0% of the company, it's enough money to indicate alignment between the leaders of the business and ordinary shareholders. You can't deny that AlzChem Group has grown its earnings per share at a very impressive rate. That's attractive. Further, the high level of insider ownership is impressive and suggests that the management appreciates the EPS growth and has faith in AlzChem Group's continuing strength. Fast growth and confident insiders should be enough to warrant further research, so it would seem that it's a good stock to follow. If you think AlzChem Group might suit your style as an investor, you could go straight to its annual report, or you could first check our discounted cash flow (DCF) valuation for the company. While opting for stocks without growing earnings and absent insider buying can yield results, for investors valuing these key metrics, here is a carefully selected list of companies in DE with promising growth potential and insider confidence. Please note the insider transactions discussed in this article refer to reportable transactions in the relevant jurisdiction. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
42 minutes ago
- Yahoo
China restricts EU imports of medical devices
HONG KONG (Reuters) -China's finance ministry said on Sunday it was restricting imports of medical devices from the European Union that exceed 45 million yuan ($6.3 million) in value. China will also restrict imports of medical devices from other countries that contain EU-made components worth more than 50% of the contract value, the finance ministry said. The measures come into force on Sunday. ($1 = 7.1645 Chinese yuan renminbi) Sign in to access your portfolio
Yahoo
42 minutes ago
- Yahoo
Accenture plc (ACN) and Palantir (PLTR) Partner to Deliver AI Solutions
Accenture plc (NYSE:ACN) is one of the 10 Best Dip Stocks to Buy According to Billionaires. On June 30, Accenture plc (NYSE:ACN) announced its partnership with Palantir Technologies Inc. (NASDAQ:PLTR) to deliver advanced AI-powered solutions to US federal government agencies. As part of the partnership, Accenture Federal Services, which is a subsidiary of Accenture plc (NYSE:ACN), has been named Palantir's preferred implementation partner for deploying its AI platforms to federal customers. Accenture Federal will train and certify 1,000 of its Data & AI professionals on Palantir's Foundry and Artificial Intelligence Platform. The company will also build a large-scale joint delivery team focused on AI automation in government. A team of data experts gathered around a computer monitor analyzing customer data. Some of the initial joint offerings by both companies include Enterprise-to-Edge data fusion, predictive supply chain orchestration, and operationalized financial intelligence. Accenture plc (NYSE:ACN) is a leading international professional services company that helps organizations improve their performance. The company operates through key areas including Strategy and Consulting, Technology, Operations, and Industry X. While we acknowledge the potential of ACN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data